Clinical trials
Hypertension trials in Malaysia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 6 |
| Not yet recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Boehringer Ingelheim | 5 |
| Sunway University | 3 |
| University of Malaya | 3 |
| Ministry of Health, Malaysia | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Sanofi | 2 |
| Universiti Putra Malaysia | 2 |
| Universiti Tunku Abdul Rahman | 2 |
| A.Menarini Asia-Pacific Holdings Pte Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 41 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Renal Insufficiency, Chronic | 5 |
| Dyslipidemias | 3 |
| Heart Failure | 3 |
| Hyperlipidemias | 3 |
| Stroke | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.